Serum IL-1?, IL-2, IL-6, and IL-8 Levels in Schizophrenia Subtypes

dc.contributor.authorKuloglu, Murat
dc.contributor.authorBayik, Yilmaz
dc.contributor.authorUnal, Ahmet
dc.contributor.authorGecici, Omer
dc.contributor.authorUstundag, Bilal
dc.date.accessioned2026-08-12T16:35:45Z
dc.date.issued2011
dc.departmentFırat Üniversitesi
dc.description.abstractSerum IL-1 beta, IL-2, IL-6, and IL-8 levels in schizophrenia subtypes Objective:The cytokines are considered to be an important topic in immunological studies of schizophrenia. In this clinical study IL-1 beta, IL-2, IL-6, and IL-8 levels were compared among schizophrenia subtypes and a control group. Method: Sixty-one patients diagnosed with schizophrenia according to the DSM-IV and 25 healthy controls were studied. The clinical and demographic information form was completed for all patients. Morning venous blood samples were collected between 8:00 and 9:00 AM from the patients and the control group. The serum IL-1 beta, IL-2, IL-6 and IL-8 levels were assessed by the ELISA method. Results: Serum IL-1 beta levels were statistically higher than the control group in patients with paranoid schizophrenia and the disorganized subtype (p<0.05). According to IL-2 levels there was a significant difference between the residual, paranoid, disorganized, and undifferentiated subtypes and the control group (p<0.01). Based on IL-6 levels a mild significant difference was observed between the residual schizophrenia subtype and the control group (p<0.05), but this difference was much more significant in the disorganized and paranoid subtypes compared to the control group (p<0.001). Serum IL-8 levels in patients with paranoid schizophrenia were statistically significantly higher than the disorganized, undifferentiated or residual subtypes, and the control group (p<0.001). Conclusions: Our results show some immunological changes in schizophrenia and these changes may be related to clinical differences in the sub-types of schizophrenia.
dc.identifier.doi10.5455/bcp.20110418011851
dc.identifier.endpage200
dc.identifier.issn1017-7833
dc.identifier.issue3
dc.identifier.orcid0000-0001-6621-2450
dc.identifier.scopus2-s2.0-80053030088
dc.identifier.scopusqualityN/A
dc.identifier.startpage193
dc.identifier.urihttps://doi.org/10.5455/bcp.20110418011851
dc.identifier.urihttps://hdl.handle.net/11508/45021
dc.identifier.volume21
dc.identifier.wosWOS:000296684400004
dc.identifier.wosqualityN/A
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherKure Iletisim Grubu A S
dc.relation.ispartofKlinik Psikofarmakoloji Bulteni-Bulletin of Clinical Psychopharmacology
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectSchizophrenia
dc.subjectcytokine
dc.subjectinterleukin
dc.titleSerum IL-1?, IL-2, IL-6, and IL-8 Levels in Schizophrenia Subtypes
dc.title.alternativeŞizofreni alt tiplerinde serum IL-1?, IL-2, IL-6 ve IL-8 düzeyleri
dc.typeArticle

Dosyalar